1384082-96-5 Usage
Description
(1r,1'S,4S)-4-methoxy-5''-methyl-6'-(5-prop-1-yn-1-ylpyridin-3-yl)-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine is a complex organic compound characterized by its unique spirocyclic structure. It features a methoxy group, a methyl group, and a propynylpyridin-3-yl group attached to a dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine core. (1r,1'S,4S)-4-methoxy-5''-methyl-6'-(5-prop-1-yn-1-ylpyridin-3-yl)-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine's configuration is (1r,1'S,4S), which specifies the stereochemistry of its chiral centers. This distinctive molecular architecture suggests potential applications in pharmaceuticals or as a research tool in biochemistry or medicinal chemistry, given its possible biological activity.
Uses
Used in Pharmaceutical Industry:
(1r,1'S,4S)-4-methoxy-5''-methyl-6'-(5-prop-1-yn-1-ylpyridin-3-yl)-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine is used as a potential pharmaceutical agent for its unique structure and potential biological activity. (1r,1'S,4S)-4-methoxy-5''-methyl-6'-(5-prop-1-yn-1-ylpyridin-3-yl)-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine's specific stereochemistry and functional groups may contribute to its interaction with biological targets, making it a candidate for the development of new drugs.
Used in Biochemistry Research:
In the field of biochemistry, (1r,1'S,4S)-4-methoxy-5''-methyl-6'-(5-prop-1-yn-1-ylpyridin-3-yl)-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine serves as a research tool to study the interactions between complex organic molecules and biological systems. Its unique structure allows scientists to investigate its binding properties, mechanism of action, and potential applications in modulating biological processes.
Used in Medicinal Chemistry:
(1r,1'S,4S)-4-methoxy-5''-methyl-6'-(5-prop-1-yn-1-ylpyridin-3-yl)-3'H-dispiro[cyclohexane-1,2'-indene-1',2''-imidazol]-4''-amine is utilized in medicinal chemistry for the design and synthesis of novel therapeutic agents. Its structural features can be further optimized to enhance its pharmacological properties, such as potency, selectivity, and bioavailability, leading to the development of more effective drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 1384082-96-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,4,0,8 and 2 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1384082-96:
(9*1)+(8*3)+(7*8)+(6*4)+(5*0)+(4*8)+(3*2)+(2*9)+(1*6)=175
175 % 10 = 5
So 1384082-96-5 is a valid CAS Registry Number.
1384082-96-5Relevant articles and documents
Compounds and their use as BACE Inhibitors
-
Page/Page column 54, (2012/07/13)
The present invention relates to compounds of formula (I) and their pharmaceutical compositions. In addition, the present invention relates to therapeutic methods for the treatment and/or prevention of Aβ-related pathologies such as Down's syndrome, β-amyloid angiopathy such as but not limited to cerebral amyloid angiopathy or hereditary cerebral hemorrhage, disorders associated with cognitive impairment such as but not limited to MCI (“mild cognitive impairment”), Alzheimer's disease, memory loss, attention deficit symptoms associated with Alzheimer's disease, neurodegeneration associated with diseases such as Alzheimer's disease or dementia including dementia of mixed vascular and degenerative origin, pre-senile dementia, senile dementia and dementia associated with Parkinson's disease, progressive supranuclear palsy or cortical basal degeneration.
